Key facts
- Syndax Pharmaceuticals priced $250 million of convertible senior notes due 2029.
- The notes will bear interest at a rate of 2.875% per annum.
- The offering is expected to close on May 20, 2024.
Syndax Pharmaceuticals has announced the pricing of its convertible senior notes. The company has priced $250 million of these notes, which are due in 2029. The notes will carry an annual interest rate of 2.875%. The offering is expected to close on May 20, 2024.